HETEROCYCLIC COMPOUNDS AS UBIQUITIN SPECIFIC PROTEASE 7 INHIBITORS

The present invention concerns inhibitors of ubiquitin specific protease 7 (USP7), and methods of use thereof. Specifically, the invention provides compounds according to formula (I), including stereoisomers, pharmaceutically acceptable salt or solvate thereof: La présente invention concerne des inh...

Full description

Saved in:
Bibliographic Details
Main Authors HELM, Matthew, O'DOWD, Colin, CRANSTON, Aaron, BURKAMP, Frank, TREDER, Adam Piotr, ROUNTREE, James Samuel Shane, PROCTOR, Lauren Emma
Format Patent
LanguageEnglish
French
Published 27.07.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention concerns inhibitors of ubiquitin specific protease 7 (USP7), and methods of use thereof. Specifically, the invention provides compounds according to formula (I), including stereoisomers, pharmaceutically acceptable salt or solvate thereof: La présente invention concerne des inhibiteurs de la protéase 7 spécifique de l'ubiquitine (USP7), et des méthodes d'utilisation de ceux-ci. Plus précisément, l'invention concerne des composés selon la formule (I), y compris des stéréoisomères, un sel ou un solvate pharmaceutiquement acceptable de ceux-ci :
Bibliography:Application Number: WO2023EP51447